BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33559907)

  • 1. Xpert Xpress Flu/RSV: Validation and impact evaluation at a large UK hospital trust.
    Morris TC; Bird PW; Horvath-Papp E; Dhillon JK; May S; Tang JW
    J Med Virol; 2021 Aug; 93(8):5146-5151. PubMed ID: 33559907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.
    Popowitch EB; Miller MB
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    Cohen DM; Kline J; May LS; Harnett GE; Gibson J; Liang SY; Rafique Z; Rodriguez CA; McGann KM; Gaydos CA; Mayne D; Phillips D; Cohen J
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
    Wolters F; Grünberg M; Huber M; Kessler HH; Prüller F; Saleh L; Fébreau C; Rahamat-Langendoen J; Thibault V; Melchers WJG
    J Med Virol; 2021 Oct; 93(10):5798-5804. PubMed ID: 34050951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of reviewing endpoint analysis for negative results on the Xpert Xpress Flu/RSV.
    Matic N; Ritchie G; Lawson T; Karakas L; Romney MG; Lowe CF
    J Med Virol; 2020 Dec; 92(12):3839-3842. PubMed ID: 32249955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the analytical and clinical performance of two RT-PCR based point-of-care tests; Cepheid Xpert® Xpress CoV-2/Flu/RSV plus and SD BioSensor STANDARD™ M10 Flu/RSV/SARS-CoV-2.
    Jensen CB; Schneider UV; Madsen TV; Nielsen XC; Ma CMG; Severinsen JK; Hoegh AM; Botnen AB; Trebbien R; Lisby JG
    J Clin Virol; 2024 Jun; 172():105674. PubMed ID: 38643722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The performance of Luminex ARIES
    McMullen P; Boonlayangoor S; Charnot-Katsikas A; Beavis KG; Tesic V
    J Clin Virol; 2017 Oct; 95():84-85. PubMed ID: 28892765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.
    Banerjee D; Kanwar N; Hassan F; Essmyer C; Selvarangan R
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30185508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults.
    Zuurbier RP; Korsten K; Verheij TJM; Butler C; Adriaenssens N; Coenen S; Gruselle O; Vantomme V; van Houten MA; Bont LJ; Wildenbeest JG;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S63-S70. PubMed ID: 35134954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Xpert Xpress Flu/RSV for the Detection of Influenza and Respiratory Syncytial Viruses.
    Liu YL; Xie TA; Lin GL; Deng W; Lin QR; Pan ZY; Fan SJ; Li ZX; Ouyang S; Zhu GD; Ji TX; Wu LJ; Xia Y; Guo XG
    Jpn J Infect Dis; 2022 Mar; 75(2):183-191. PubMed ID: 34053954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.
    Leung EC; Chow VC; Lee MK; Tang KP; Li DK; Lai RW
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33436456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China.
    Zou X; Chang K; Wang Y; Li M; Zhang W; Wang C; Lu B; Xiong Z; Han J; Zhang Y; Zhao J; Cao B;
    Int J Infect Dis; 2019 Mar; 80():92-97. PubMed ID: 30634045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.
    Schmidt RLJ; Simon A; Popow-Kraupp T; Laggner A; Haslacher H; Fritzer-Szekeres M; Redlberger-Fritz M; Mayer FJ
    Clin Microbiol Infect; 2019 Aug; 25(8):1032-1037. PubMed ID: 30583060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment.
    Shihabuddin BS; Faron ML; Relich RF; Van Heukelom P; Mayne D; Staat MA; Selvarangan R; Hueschen LA; Wolk DM; House S; Harnett G; McGann K; Steele MT; Romero JR; Arms J; Lander O; Loeffelholz M; Strouts F; Cohen D
    Diagn Microbiol Infect Dis; 2022 Oct; 104(2):115764. PubMed ID: 35917666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses.
    Chen JH; Lam HY; Yip CC; Cheng VC; Chan JF; Leung TH; Sridhar S; Chan KH; Tang BS; Yuen KY
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):177-180. PubMed ID: 29262988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Cepheid Xpert Flu/RSV XC and BioFire FilmArray for Detection of Influenza A, Influenza B, and Respiratory Syncytial Virus.
    Wahrenbrock MG; Matushek S; Boonlayangoor S; Tesic V; Beavis KG; Charnot-Katsikas A
    J Clin Microbiol; 2016 Jul; 54(7):1902-1903. PubMed ID: 27098956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
    Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
    J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses.
    Ling L; Kaplan SE; Lopez JC; Stiles J; Lu X; Tang YW
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.